| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-25 | FY 2024
FILED 2024-12-26 | FY 2023
FILED 2023-12-28 |
|---|---|---|---|
| Revenue (Total Sales) | $4.68B | $4.46B | $4.41B |
| YoY Revenue Growth % | +5.1% | +0.9% | — |
| Gross Profit | $2.04B | $1.93B | — |
| Gross Margin % | 43.6% | 43.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $270.1M | $256.2M | $321.4M |
| Operating Margin % | 5.8% | 5.7% | 7.3% |
| Net Income (GAAP) | $208.6M | $205.9M | $246.0M |
| EBITDA (Normalized) | $438.7M | $416.6M | $480.3M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $381.8M | $603.2M | $803.6M |
| Capital Expenditures (CapEx) | $210.8M | $200.5M | $198.6M |
| Free Cash Flow (FCF) | $171.1M | $402.6M | $605.0M |
| FCF Margin % | 3.7% | 9.0% | 13.7% |
| Return on Invested Capital (ROIC %) | 10.7% | 11.2% | 7.9% |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $193.6M | $194.5M | $1.24B |
| Total Stockholders' Equity | $2.41B | $2.17B | $2.54B |